The pharmacy benefits industry can learn ways to streamline processes, make cost-effective changes, and increase efficiency by listening to patients with chronic illness.
This study examines variations in overall use, and potentially inappropriate use, of non-warfarin direct-acting oral anticoagulants across sites within the Veterans Health Administration.
There is a constant balancing act for health care systems to provide the newest and most up-to-date care for patients while being financially responsible.
Push continues for more access to EpiPens, but it is important to protect health care providers who administer the treatment.
The ampule of digoxin was accidentally taken from automated dispensing cabinet instead of bupivacaine
Resulting economic decline Is forces many to make hard choices about medications, but pharmacists can increase awareness and offer solutions.
This study evaluates the impact of primary and secondary nonadherence to cholesterol medication on low-density lipoprotein levels, emergency department visits, and hospitalizations.
This pilot study analyzes the cost savings of utilizing a prescription medical food, serum-derived bovine immunoglobulin/protein isolate, for the management of inflammatory bowel disease in a small cohort.
The increased emphasis on interoperability and interconnectedness in health care brings challenges and rewards to pharmacists.
A proposed mechanism underlying observed sex differences in HIV-associated vascular risk is increased immune activation in women.
Fibromyalgia was related to a pattern of initial increase in utilization and costs, followed by a decrease 7 to 12 months after diagnosis.
For ARB-class antihypertensive agents, we examined the association among initial prescription supply days (ie, 30- or 90-day) and adherence, hospitalization risk, and healthcare use.
This paper explores the economic incentives that oncologists face when deciding between oral and intravenous oncolytics and their impact on prescribing behavior.
Here is an overview of the key Issues for hospital pharmacists.
Executive-level pharmacy leaders in US managed care organizations identify how healthcare reform is driving changes in pharmacy benefit management.
This study assesses comparative resource use for patients given a new diagnosis of nonvalvular atrial fibrillation treated with dabigatran or warfarin in a real-world setting.
In a short time, COVID-19 has increased our dependency on technology and pharmaceutical companies are actively investigating this digital transformation.
Pharmacy students are often told that there are many avenues to their pharmacy careers. This is especially true with the changing landscape of the profession.
Frances Sochovka was an extraordinary woman. She was dad's favorite aunt, and I was quite fond of her.
The shift from fee-based, volume-driven care to value-based, patient-centered care and the growth of specialty pharmaceuticals are propelling us all into uncharted territory, no matter what role you play in health care.
For a current compounder or someone looking to enter the space, it is imperative that their business remains on top of the latest compounding developments.
The shift from fee-based, volume-driven care to value-based, patient-centered care and the growth of specialty pharmaceuticals are propelling us all into uncharted territory, no matter what role you play in health care.
Pharmacists should develop treatment plans with an active interdisciplinary team and patient involvement.